Use of Hair to Diagnose Breast Cancer
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00390377 |
Recruitment Status
: Unknown
Verified October 2006 by Fermiscan Ltd.
Recruitment status was: Recruiting
First Posted
: October 19, 2006
Last Update Posted
: October 19, 2006
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
This study aims to perform x-ray diffraction analysis of blinded hair samples from women with a documented health status, to validate the previous findings of James et al who described that x-ray diffraction patterns of human hair can distinguish samples from healthy subjects from those of diseased subjects, specifically those suffering from breast cancer.
The primary hypothesis is that x-ray diffraction of hair can be used to distinguish hair from patients with confirmed breast cancer from subjects without detectable breast cancer.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Breast Cancer | Procedure: Cutting scalp hair | Phase 2 |
Study Type : | Interventional (Clinical Trial) |
Enrollment : | 240 participants |
Allocation: | Non-Randomized |
Intervention Model: | Single Group Assignment |
Masking: | Single |
Primary Purpose: | Diagnostic |
Official Title: | A Study to Evaluate a Test for the Diagnosis of Breast Cancer Using X-Ray Diffraction of Hair Fibres. |
Study Start Date : | October 2006 |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 20 Years and older (Adult, Senior) |
Sexes Eligible for Study: | Female |
Inclusion Criteria:
- Adult women (aged >20) who are undergoing mammography, and
- Who are willing and able to provide informed consent; and
- Who have usable scalp hair
Exclusion Criteria:
- Women with a history of breast cancer ever or other cancers (excluding non-melanoma skin cancer and CIN: cervical intra-epithelial neoplasia) within 5 years.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00390377
Contact: Peter W French, BSc, MSc, PhD | +61292454460 | pfrench@fermiscan.com.au |
Australia, New South Wales | |
St George Private Hospital | Recruiting |
Sydney, New South Wales, Australia, 2217 | |
Principal Investigator: Ronald Shnier, MBBS, FRACR |
Principal Investigator: | Ronald Shnier, MBBS, FRACR | Symbion Health | |
Study Director: | Gary Corino, BSc | Fermiscan Ltd |
Publications:
ClinicalTrials.gov Identifier: | NCT00390377 History of Changes |
Other Study ID Numbers: |
FT240-2006 |
First Posted: | October 19, 2006 Key Record Dates |
Last Update Posted: | October 19, 2006 |
Last Verified: | October 2006 |
Keywords provided by Fermiscan Ltd:
x-ray diffraction hair breast cancer synchrotron |
Additional relevant MeSH terms:
Breast Neoplasms Neoplasms by Site Neoplasms Breast Diseases Skin Diseases |